![](/img/cover-not-exists.png)
SAT-330 COULD ADDING BORTEZOMIB HAVE BENEFIT FOR ANTIBODY MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION?
Dalili MD, N., Nafar, M., Panahandeh, M., Navid, P.Volume:
5
Journal:
Kidney International Reports
DOI:
10.1016/j.ekir.2020.02.350
Date:
March, 2020
File:
PDF, 337 KB
2020